UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported) June 29, 2006
Baxter International Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
|
|
1-4448
|
|
36-0781620 |
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
|
|
|
One Baxter Parkway, Deerfield, Illinois
|
|
60015-4633 |
|
(Address of principal executive offices)
|
|
(Zip Code) |
(847) 948-2000
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 1.01. Entry into a Material Definitive Agreement
On
June 29, 2006, Baxter Healthcare Corporation, a direct wholly-owned subsidiary of Baxter
International Inc., entered into a Consent Decree for Condemnation and Permanent
Injunction (the Consent Decree) with the United States to resolve the previously reported
seizure litigation related to Baxters COLLEAGUE and SYNDEO
pumps.
A copy of the Consent Decree is filed as Exhibit 10.1 hereto and is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(d) |
|
The following exhibit is filed herewith: |
|
10.1 |
|
Consent Decree for Condemnation and Permanent Injunction between Baxter
Healthcare Corporation and the United States. |